Do pathological fractures influence survival and local recurrence rate in bony sarcomas?

European Journal of Cancer

Volumn 43, Issue 13, 2007, Pages 1944-1951

  Bramer, J A M ^a,b   Abudu, A A ^b   Grimer, R J ^b   Carter, S R ^b   Tillman, R M ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Chondrosarcoma; Ewing's sarcoma; Local recurrence; Osteosarcoma; Pathological fracture; Prognosis; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CHONDROSARCOMA; CONTROLLED STUDY; DISEASE SEVERITY; EWING SARCOMA; FEMALE; FRACTURE; HUMAN; HUMAN TISSUE; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARM BONES; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHONDROSARCOMA; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; LEG BONES; LIMB SALVAGE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34548044692     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.07.004     Document Type: Article

References (29)

1. Abudu A., Sferopoulos N.K., Tillman R.M., Carter S.R., and Grimer R.J. The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br 78 (1996) 694-698
2. Lee F.Y., Mankin H.J., Fondren G., et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81 (1999) 326-338
3. Bacci G., Ferrari S., Longhi A., et al. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 74 (2003) 449-454
4. Scully S.P., Ghert M.A., Zurakowski D., Thompson R.C., and Gebhardt M.C. Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am 84A (2002) 49-57
5. Zeifang F., Sabo D., and Ewerbeck V. Pathological fracture in primary malignant bone tumors. Chirurg 71 (2000) 1121-1125
6. Hoffmann C., Jabar S., Ahrens S., et al. Prognosis in Ewing sarcoma patients with initial pathological fractures of the primary tumor site. Klin Padiatr 207 (1995) 151-157
7. Souhami R.L., Craft A.W., Van der Eijken J.W., et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 350 (1997) 911-917
8. Bramwell V.H., Steward W.P., Nooij M., et al. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study. J Clin Oncol 17 (1999) 3260-3269
9. Cotterill S.J., Ahrens S., Paulussen M., et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18 (2000) 3108-3114
10. Craft A., Cotterill S., Malcolm A., et al. Ifosfamide-containing chemotherapy in Ewing's sarcoma: the Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J Clin Oncol 16 (1998) 3628-3633
11. Enneking W.F., Spanier S.S., and Goodman M.A. Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg Am 62 (1980) 1027-1030
12. Rosen G., Caparros B., Huvos A.G., et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49 (1982) 1221-1230
13. Huvos A.G., Rosen G., and Marcove R.C. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101 (1977) 14-18
14. Jaffe N., Spears R., Eftekhari F., et al. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival. Cancer 59 (1987) 701-709
15. Dahlin D.C. Osteosarcoma of bone and a consideration of prognostic variables. Cancer Treat Rep 62 (1978) 189-192
16. Ebeid W., Amin S., and Abdelmegid A. Limb salvage management of pathologic fractures of primary malignant bone tumors. Cancer Control 12 (2005) 57-61
17. Glasser D.B., Lane J.M., Huvos A.G., Marcove R.C., and Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma: the memorial hospital experience. Cancer 69 (1992) 698-708
18. Bacci G. Pathologic fracture in osteosarcoma. J Bone Joint Surg Am 85A (2003) 1848-1849
19. Mervak T.R., Unni K.K., Pritchard D.J., and McLeod R.A. Telangiectatic osteosarcoma. Clin Orthop Relat Res (1991) Issue 270
20. Bergh P., Gunterberg B., Meis-Kindblom J.M., and Kindblom L.G. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 91 (2001) 1201-1212
21. Rizzo M., Ghert M.A., Harrelson J.M., and Scully S.P. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop Relat Res (2001) 224-233
22. Ozaki T., Lindner N., Hillmann A., Rodl R., Blasius S., and Winkelmann W. Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer 77 (1996) 1292-1297
23. Fiorenza F., Abudu A., Grimer R.J., et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Ser B 84 1 (2002) 93-99
24. Wang J.W., Ger L.P., Shih C.H., and Hsieh M.C. Chondrosarcoma of bone: a statistical analysis of prognostic factors. J Formos Med Assoc 90 (1991) 998-1003
25. Pritchard D.J., Lunke R.J., Taylor W.F., Dahlin D.C., and Medley B.E. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 45 (1980) 149-157
26. Wagner L.M., Neel M.D., Pappo A.S., et al. Fractures in pediatric Ewing sarcoma. J Pediatr Hematol Oncol 23 (2001) 568-571
27. Fuchs B., Valenzuela R.G., and Sim F.H. Pathologic fracture as a complication in the treatment of Ewing's sarcoma. Clin Orthop Relat Res (2003) 25-30
28. Wunder J.S., Paulian G., Huvos A.G., Heller G., Meyers P.A., and Healey J.H. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 80 (1998) 1020-1033
29. Bacci G., Longhi A., Versari M., Mercuri M., Briccoli A., and Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106 (2006) 1154-1161